ÌÇÐÄvlog

[Skip to Navigation]
Sign In
Editor's Note
April 15, 2024

RSV Vaccination—The Juice Is Worth the Squeeze

Author Affiliations
  • 1Associate Editor, JAMA Internal Medicine
JAMA Intern Med. 2024;184(6):611. doi:10.1001/jamainternmed.2024.0219

In this issue of JAMA Internal Medicine, Woodruff et al1 present a cross-sectional study of patients 50 years and older who were hospitalized and tested positive for respiratory syncytial virus (RSV), reporting that 22% experienced an acute cardiac event, including acute exacerbation of heart failure or myocardial injury. The already high in-hospital mortality rate of 5% for older adults with RSV-associated hospitalizations was doubled among those experiencing a concurrent acute cardiac event.

Add or change institution
×